Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 12110
TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679652(US20240182482, Compound 66 | US20240182482, Compou...)
Affinity DataIC50: 1.19nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679456(US20240182482, Compound 1 | (6-(5-fluoro-2-((2-met...)
Affinity DataIC50: 1.52nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679652(US20240182482, Compound 66 | US20240182482, Compou...)
Affinity DataIC50: 1.54nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679624(US20240182482, Compound 65 | US20240182482, Compou...)
Affinity DataIC50: 1.56nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679456(US20240182482, Compound 1 | (6-(5-fluoro-2-((2-met...)
Affinity DataIC50: 1.67nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679624(US20240182482, Compound 65 | US20240182482, Compou...)
Affinity DataIC50: 1.84nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679652(US20240182482, Compound 66 | US20240182482, Compou...)
Affinity DataIC50: 1.86nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679457(US20240182482, Compound 2)
Affinity DataIC50: 1.96nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679624(US20240182482, Compound 65 | US20240182482, Compou...)
Affinity DataIC50: 1.97nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679619(US20240182482, Compound 23 | US20240182482, Compou...)
Affinity DataIC50: 2.05nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679493(US20240182482, Compound 19)
Affinity DataIC50: 2.08nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679621(US20240182482, Compound 28)
Affinity DataIC50: 2.33nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679461(US20240182482, Compound 4)
Affinity DataIC50: 2.47nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679458(US20240182482, Compound 3)
Affinity DataIC50: 2.48nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679620(US20240182482, Compound 24)
Affinity DataIC50: 2.49nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679485(US20240182482, Compound 14)
Affinity DataIC50: 2.71nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679484(US20240182482, Compound 5)
Affinity DataIC50: 2.79nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679619(US20240182482, Compound 23 | US20240182482, Compou...)
Affinity DataIC50: 3.36nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM679456(US20240182482, Compound 1 | (6-(5-fluoro-2-((2-met...)
Affinity DataIC50: 3.47nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM50240826(AZD-1775 | MK-1775 | US11124518, Example AZD1775 |...)
Affinity DataIC50: 4.38nMAssay Description:After the serially diluted compound and an enzyme were mixed, the mixture was incubated at room temperature (25° C.) for 15 min, and then centrifuged...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2024
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)